NCT/Study#

NCT04894591 /

JZP712-402 EMERGE

Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients with Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca (EMERGE 402)

Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients with Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca (EMERGE 402)

DISEASE GROUP:
Lung
current phase:
N/A
STUDY STATUS:
Accepting Patients
Location:
Freehold, NJ, Little Silver,NJ
For More information: